326 related articles for article (PubMed ID: 33718400)
1. Approaches and Challenges in the Management of Multiple Myeloma in the Very Old: Future Treatment Prospects.
Kaweme NM; Changwe GJ; Zhou F
Front Med (Lausanne); 2021; 8():612696. PubMed ID: 33718400
[TBL] [Abstract][Full Text] [Related]
2. Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.
Wildes TM; Campagnaro E
J Geriatr Oncol; 2017 Jan; 8(1):1-7. PubMed ID: 27118356
[TBL] [Abstract][Full Text] [Related]
3. Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper.
Grant SJ; Mian HS; Giri S; Boutin M; Dottorini L; Neuendorff NR; Krok-Schoen JL; Nikita N; Rosko AE; Wildes TM; Zweegman S
J Geriatr Oncol; 2021 May; 12(4):499-507. PubMed ID: 33342724
[TBL] [Abstract][Full Text] [Related]
4. Managing multiple myeloma in elderly patients.
Diamond E; Lahoud OB; Landau H
Leuk Lymphoma; 2018 Jun; 59(6):1300-1311. PubMed ID: 28847191
[TBL] [Abstract][Full Text] [Related]
5. Management of older and frail patients with multiple myeloma in the Portuguese routine clinical practice: Deliberations and recommendations from an expert panel of hematologists.
João C; Geraldes C; Neves M; Mariz M; Trigo F
J Geriatr Oncol; 2020 Nov; 11(8):1210-1216. PubMed ID: 32601004
[TBL] [Abstract][Full Text] [Related]
6. Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies).
Fialová D; Laffon B; Marinković V; Tasić L; Doro P; Sόos G; Mota J; Dogan S; Brkić J; Teixeira JP; Valdiglesias V; Costa S;
Eur J Clin Pharmacol; 2019 Apr; 75(4):451-466. PubMed ID: 30610276
[TBL] [Abstract][Full Text] [Related]
7. Elderly patients with multiple myeloma: towards a frailty approach?
Zweegman S; Engelhardt M; Larocca A;
Curr Opin Oncol; 2017 Sep; 29(5):315-321. PubMed ID: 28763310
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma in the older adult: better prospects, more challenges.
Wildes TM; Rosko A; Tuchman SA
J Clin Oncol; 2014 Aug; 32(24):2531-40. PubMed ID: 25071143
[TBL] [Abstract][Full Text] [Related]
9. Geriatric Assessment in Older Adults with Multiple Myeloma.
Wildes TM; Tuchman SA; Klepin HD; Mikhael J; Trinkaus K; Stockerl-Goldstein K; Vij R; Colditz G
J Am Geriatr Soc; 2019 May; 67(5):987-991. PubMed ID: 30548581
[TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma: Current and future management in the aging population.
Fotiou D; Ntanasis-Stathopoulos I; Gavriatopoulou M; Dimopoulos MA
Maturitas; 2020 Aug; 138():8-13. PubMed ID: 32631590
[TBL] [Abstract][Full Text] [Related]
11. Management of Newly Diagnosed Elderly Multiple Myeloma Patients.
Antoine-Pepeljugoski C; Braunstein MJ
Curr Oncol Rep; 2019 May; 21(7):64. PubMed ID: 31127403
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma Patients.
Bonello F; Boccadoro M; Larocca A
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33114320
[TBL] [Abstract][Full Text] [Related]
13. Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide.
Schoenbeck KL; Wildes TM
Clin Interv Aging; 2020; 15():619-633. PubMed ID: 32440105
[TBL] [Abstract][Full Text] [Related]
14. Short overview on the current standard of treatment in newly diagnosed multiple myeloma.
Willenbacher E; Balog A; Willenbacher W
Memo; 2018; 11(1):59-64. PubMed ID: 29606980
[TBL] [Abstract][Full Text] [Related]
15. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
16. Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis.
Salazar AS; Recinos LM; Mian HS; Stoll C; Simon LE; Sekhon S; Colditz GA; Wildes TM
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):488-496.e6. PubMed ID: 31133527
[TBL] [Abstract][Full Text] [Related]
17. Special considerations for the treatment of multiple myeloma according to advanced age, comorbidities, frailty and organ dysfunction.
Fraz MA; Warraich FH; Warraich SU; Tariq MJ; Warraich Z; Khan AY; Usman M; Ijaz A; Tenneti P; Mushtaq A; Akbar F; Shahid Z; Ali Z; Fazeel HM; Rodriguez C; Nasar A; McBride A; Anwer F
Crit Rev Oncol Hematol; 2019 May; 137():18-26. PubMed ID: 31014512
[TBL] [Abstract][Full Text] [Related]
18. Frail Multiple Myeloma Patients Deserve More Than Just a Score.
Miller HL; Sharpley FA
Hematol Rep; 2023 Feb; 15(1):151-156. PubMed ID: 36975728
[TBL] [Abstract][Full Text] [Related]
19. Determining treatment intensity in elderly patients with multiple myeloma.
Salvini M; D'Agostino M; Bonello F; Boccadoro M; Bringhen S
Expert Rev Anticancer Ther; 2018 Sep; 18(9):917-930. PubMed ID: 29972740
[TBL] [Abstract][Full Text] [Related]
20. How I treat fragile myeloma patients.
Larocca A; Palumbo A
Blood; 2015 Nov; 126(19):2179-85. PubMed ID: 26324701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
